November 18, 2014
The Pharmaceutical Affairs and Food Sanitation Council’s (PAFSC) Second Committee on Drugs, an advisory body to the health minister, will discuss on November 28 whether to approve seven active pharmaceutical ingredients including Novartis Pharma’s secukinumab (recombinant). Secukinumab has a novel...read more